About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
M
Integrating MMR/MSI, RAS, BRAF, and HER2 as Targetable Biomarkers Into the Management of mCRC
By
Marc Peeters
2 Videos
173 views
June 27, 2024
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
16:57
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…
Feat.
V. Subbiah
23:58
ASCO GI 2023 Conference Coverage
ASCO GI 2023 Key Studies
Feat.
R. Kim,
R. Mehta
15:51
Total Health
2024 Updates on 1L MSI-H/dMMR mCRC and Using ctDNA MRD Testing in Ea…
Feat.
A. Grothey
13:29
Ibrahim Sahin
Treating KRAS-Mutated mCRC
09:25
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Expert Panel Discussion on CRC Including T…
Feat.
N. Uboha,
K. Spencer,
M. Cecchini
22:27
2024 ASCO® Annual Meeting Insights Hub
Developmental Therapeutics Highlights From ASCO® 2024
Feat.
G. Sonpavde
55:10
University of Colorado Cancer Center
History of Cancer and Its Treatment: What Will It Take to Cure?
Feat.
C. Lieu
18:02
Ibrahim Sahin
Treating HER2-Amplified mCRC
06:51
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "PanaMa Trial - FU/FA Maintenance Therapy …
Feat.
D. Modest
18:23
Ibrahim Sahin
Treating BRAF-Mutated mCRC
11:57
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Phase III FIRE-4 Study - Influence of Bas…
Feat.
S. Stintzing
15:56
Van Morris
ASCO Updated Guidelines for the Treatment of Metastatic Colorectal C…
Feat.
C. Eng
07:16
Insights from 2024 ASCO® GI Annual Meeting
ASCO® GI 2024 Panel Discussion: "CheckMate-8HW Clinical Implica…
Feat.
Y. Janjigian,
S. Cytryn,
S. Klempner
16:39
UChicago Medicine
Treatment of mCRC After Standard Chemotherapy
Feat.
A. Shergill
12:29
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Fruquintinib in Refractory mCRC"
Feat.
C. Eng
06:26
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "64-Month Follow-Up From CheckMate 142 - 1…
Feat.
H. Lenz
15:31
Shivaani Kummar
Clinical Implications of Tumor Agnostic Therapies
18:34
Total Health
Management of Colorectal Liver Metastases
Feat.
S. Gholami
21:24
Fred Hutchinson Cancer Center
Re-Challenge With Systemic Therapy for mCRC
Feat.
R. Hsieh
07:59
Insights from 2024 ESMO GI Annual Meeting
ESMO GI 2024 Insights: DEEPER Trial - m-FOLFOXIRI + Cetuximab vs. Be…
Feat.
Y. Sunakawa
